Free access to medicines for the treatment of chronic diseases in brazil

Show simple item record

dc.contributor.author Leao Tavares, Noemia Urruth
dc.contributor.author Luiza, Vera Lucia
dc.contributor.author Oliveira, Maria Auxiliadora
dc.contributor.author Costa, Karen Sarmento
dc.contributor.author Mengue, Sotero Serrate
dc.contributor.author Dourado Arrais, Paulo Sergio
dc.contributor.author Ramos, Luiz Roberto [UNIFESP]
dc.contributor.author Farias, Mareni Rocha
dc.contributor.author Dal Pizzol, Tatiane da Silva
dc.contributor.author Bertoldi, Andrea Damaso
dc.date.accessioned 2019-01-21T10:29:36Z
dc.date.available 2019-01-21T10:29:36Z
dc.date.issued 2016
dc.identifier http://dx.doi.org/10.1590/s1518-8787.2016050006118
dc.identifier.citation Revista De Saude Publica. Sao paulo, v. 50, n. 2, p. 7s, 2016.
dc.identifier.issn 0034-8910
dc.identifier.uri http://repositorio.unifesp.br/handle/11600/49282
dc.description.abstract OBJECTIVE: To analyze the free access to medicines for the treatment of chronic diseases in the Brazilian population, according to demographic and socioeconomic factors. We also analyzed the most used pharmacological groups, according to funding source: free-of-charge or out-of-pocket paid. METHODS: Analysis of data from the Pesquisa Nacional sobre Acesso, Utilizacao e Promocao do Uso Racional de Medicamentos (PNAUM - National Survey on Access, Use and Promotion of Rational Use of Medicines), a population-based household survey, of cross-sectional design, based on probabilistic sample of the Brazilian population. We analyzed as outcome the prevalence of free access (free-of-charge) to all medicines for treatment of the reported chronic diseases, in the last 30 days. We studied the following independent variables: sex, age group, education in complete years of school, economic class, health plan, and geographical region of residence. We estimated the prevalences and 95% confidence intervals (95% CI) and applied the Pearson's Chi-squared test to assess the differences between the groups, considering a 5% significance level. RESULTS: About half of adults and older adults who have had full access to the treatment of chronic diseases in Brazil obtained all needed medicines for free (47.5% en
dc.description.abstract 95% CI 45.1-50.0). The prevalences of free access were higher among men (51.4% en
dc.description.abstract 95% CI 48.1-54.8), age group of 40-59 years (51.1% en
dc.description.abstract 95% CI 48.1-54.2), and in the poorest social classes (53.9% en
dc.description.abstract 95% CI 50.2-57.7). The majority of medicines that act on the cardiovascular system, such as diuretics (C03) (78.0% en
dc.description.abstract 95% CI 75.2-80.5), beta-blockers (C07) (62.7% en
dc.description.abstract 95% CI 59.4-65.8), and the agents that work in the renin-angiotensin system (C09) (73.4% en
dc.description.abstract 95% CI 70.8-75.8), were obtained for free. Medicines that act on the respiratory system, such as agents against obstructive airway diseases (R03) (60.0% en
dc.description.abstract 95% CI 52.7-66.9) were mostly paid with own resources. CONCLUSIONS: Free access to medicines for treatment of chronic diseases occurs to a considerable portion of the Brazilian population, especially for the poorest ones, indicating decreased socioeconomic inequalities, but with differences between regions and between some classes of medicines. en
dc.description.sponsorship Department of Pharmaceutical Services and Strategic Health Supplies (DAF) of the Secretariat of Science, Technology and Strategic Inputs (SCTIE) of the Ministry of Health (SCTIE/MS) [25000.111834/2011-31]
dc.description.sponsorship Department of Science and Technology (DECIT) of the Secretariat of Science, Technology and Strategic Inputs (SCTIE) of the Ministry of Health (SCTIE/MS) [25000.111834/2011-31]
dc.format.extent 7s
dc.language.iso eng
dc.publisher Dove Medical Press Ltd
dc.relation.ispartof Revista De Saude Publica
dc.rights Acesso aberto
dc.subject Minas-Gerais State en
dc.subject Health-Care en
dc.subject Southern Brazil en
dc.subject Belo-Horizonte en
dc.subject Expenditures en
dc.subject Inequalities en
dc.subject Prevalence en
dc.subject Medication en
dc.subject System en
dc.subject Drugs en
dc.title Free access to medicines for the treatment of chronic diseases in brazil en
dc.title Acesso gratuito a medicamentos para tratamento de doenças crônicas no Brasil pt
dc.type Artigo
dc.description.affiliation Departamento de Farmácia. Faculdade de Ciências da Saúde. Universidade de Brasília. Brasília, DF, Brasil
dc.description.affiliation Departamento de Política de Medicamentos e Assistência Farmacêutica. Escola Nacional de Saúde Pública Sérgio Arouca. Fundação Oswaldo Cruz. Rio de Janeiro, RJ, Brasil
dc.description.affiliation Núcleo de Estudos de Políticas Públicas. Universidade Estadual de Campinas. Campinas, SP, Brasil
dc.description.affiliation Programa de Pós-Graduação em Epidemiologia. Universidade Federal do Rio Grande do Sul. Porto Alegre, RS, Brasil
dc.description.affiliation Departamento de Farmácia. Faculdade de Farmácia, Odontologia e Enfermagem. Universidade Federal do Ceará. Fortaleza, CE, Brasil
dc.description.affiliation Departamento de Medicina Preventiva. Escola Paulista de Medicina. Universidade Federal de São Paulo. São Paulo, SP, Brasil
dc.description.affiliation Departamento de Ciências Farmacêuticas, Centro de Ciências da Saúde. Universidade Federal de Santa Catarina. Florianópolis, SC, Brasil
dc.description.affiliation Departamento de Produção e Controle de Medicamentos. Faculdade de Farmácia. Universidade Federal do Rio Grande do Sul. Porto Alegre, RS, Brasil
dc.description.affiliation Departamento de Medicina Social. Faculdade de Medicina. Universidade Federal de Pelotas. Pelotas, RS, Brasil
dc.description.affiliationUnifesp Departamento de Medicina Preventiva. Escola Paulista de Medicina. Universidade Federal de São Paulo. São Paulo, SP, Brasil
dc.description.sponsorshipID SCTIE/MS: 25000.111834/2011-31
dc.identifier.file S0034-89102016000300313.pdf
dc.identifier.scielo S0034-89102016000300313
dc.identifier.doi 10.1590/S1518-8787.2016050006118
dc.description.source Web of Science
dc.identifier.wos WOS:000391447400003



File

File Size Format View

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record

Search


Browse

Statistics

My Account